| NCT03399708 |
Immune Metabolic Associations in Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT03399708 |
Completed |
NHS Greater Glasgow and Clyde |
2019-10-12 |
| NCT03284879 |
Post-Marketing Surveillance Study of OTEZLA |
https://ClinicalTrials.gov/show/NCT03284879 |
Recruiting |
Amgen |
2021-08-31 |
| NCT04439526 |
A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis |
https://ClinicalTrials.gov/show/NCT04439526 |
Recruiting |
Janssen-Cilag S.p.A. |
2023-06-30 |
| NCT04316533 |
Work Stress and Impact of Pruritus on Quality of Life |
https://ClinicalTrials.gov/show/NCT04316533 |
Completed |
University Hospital, Brest |
2020-06-30 |
| NCT03402828 |
Body PSOriasis: Long-term Relapse CONTROL |
https://ClinicalTrials.gov/show/NCT03402828 |
Active, not recruiting |
LEO Pharma |
2020-07-01 |
| NCT03361215 |
Disease Trajectories in Atopic Dermatitis and Psoriasis |
https://ClinicalTrials.gov/show/NCT03361215 |
Recruiting |
University of Schleswig-Holstein |
2027-01-01 |
| NCT03358914 |
The PsoTeenQOL - Preliminary Reliability and Validity |
https://ClinicalTrials.gov/show/NCT03358914 |
Completed |
University of Aarhus |
2019-01-15 |
| NCT03339089 |
Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT03339089 |
Recruiting |
AbbVie |
2021-06-30 |
| NCT03223012 |
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service |
https://ClinicalTrials.gov/show/NCT03223012 |
Completed |
AbbVie |
2019-02-28 |
| NCT03198390 |
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions |
https://ClinicalTrials.gov/show/NCT03198390 |
Recruiting |
University of Arizona |
2020-07-01 |
| NCT03099083 |
Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab |
https://ClinicalTrials.gov/show/NCT03099083 |
Completed |
AbbVie |
2019-04-05 |
| NCT02978001 |
Insulin Sensitivity, Glucose - and Fat Metabolism in Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT02978001 |
Completed |
University Hospital, Gentofte, Copenhagen |
2019-01-01 |
| NCT02954081 |
APremilast After FumaRic Acid Ester Treatment |
https://ClinicalTrials.gov/show/NCT02954081 |
Recruiting |
Amgen |
2022-05-27 |
| NCT02935582 |
PSOREAL - Managing PSOriasis in the REAL World |
https://ClinicalTrials.gov/show/NCT02935582 |
Recruiting |
LEO Pharma |
2023-12-31 |
| NCT02910791 |
The Role of Bacterial Toxins in Human Skin Disease |
https://ClinicalTrials.gov/show/NCT02910791 |
Recruiting |
National Jewish Health |
2022-12-31 |
| NCT02899429 |
Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of Psoriasis |
https://ClinicalTrials.gov/show/NCT02899429 |
Completed |
University Hospital, Brest |
2015-12-31 |
| NCT02881346 |
Efficacy and Tolerability of Enstilar® in Daily Practice |
https://ClinicalTrials.gov/show/NCT02881346 |
Completed |
LEO Pharma |
2017-03-31 |
| NCT02856542 |
Real-life Evaluation of the Daivobet® Gel Applicator |
https://ClinicalTrials.gov/show/NCT02856542 |
Completed |
LEO Pharma |
2017-06-30 |
| NCT03218488 |
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 12 Years and Older With Moderate to Severe Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT03218488 |
Recruiting |
Janssen-Cilag International NV |
2026-09-15 |
| NCT02796014 |
Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis |
https://ClinicalTrials.gov/show/NCT02796014 |
Completed |
Istanbul Medeniyet University |
2017-03-31 |
| NCT02752672 |
Study on the Therapeutic Mechanisms of Dithranol Treatment in Patients With Chronic Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT02752672 |
Completed |
Medical University of Graz |
2016-11-30 |
| NCT02750800 |
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) |
https://ClinicalTrials.gov/show/NCT02750800 |
Completed |
AbbVie |
2018-04-03 |
| NCT02740218 |
A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice |
https://ClinicalTrials.gov/show/NCT02740218 |
Recruiting |
Amgen |
2021-04-30 |
| NCT02713295 |
A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece |
https://ClinicalTrials.gov/show/NCT02713295 |
Completed |
AbbVie |
2019-04-19 |
| NCT02668341 |
Cross Sectional Analysis of Healthcare for Psoriasis in 5 European Countries |
https://ClinicalTrials.gov/show/NCT02668341 |
Enrolling by invitation |
Universitätsklinikum Hamburg-Eppendorf |
2020-09-30 |
| NCT02652494 |
Observational Study of Apremilast in Patients With Psoriasis in The Netherlands |
https://ClinicalTrials.gov/show/NCT02652494 |
Active, not recruiting |
Amgen |
2019-12-31 |
| NCT02636101 |
Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study |
https://ClinicalTrials.gov/show/NCT02636101 |
Completed |
LEO Pharma |
2018-02-15 |
| NCT02626793 |
A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions |
https://ClinicalTrials.gov/show/NCT02626793 |
Completed |
Amgen |
2017-06-08 |
| NCT02570750 |
The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis |
https://ClinicalTrials.gov/show/NCT02570750 |
Completed |
Pfizer |
2016-12-05 |
| NCT00508547 |
Psoriasis Longitudinal Assessment and Registry (PSOLAR) |
https://ClinicalTrials.gov/show/NCT00508547 |
Recruiting |
Janssen Scientific Affairs, LLC |
2021-05-31 |
| NCT02503059 |
Etanercept Survival in Elderly Population |
https://ClinicalTrials.gov/show/NCT02503059 |
Completed |
Andalusian Network for Design and Translation of Advanced Therapies |
2015-01-31 |
| NCT02486302 |
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. |
https://ClinicalTrials.gov/show/NCT02486302 |
Completed |
Pfizer |
2017-12-11 |
| NCT02451839 |
An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) |
https://ClinicalTrials.gov/show/NCT02451839 |
Completed |
AbbVie |
2017-12-05 |
| NCT02417792 |
The Association Between Psoriasis and Intestinal Bacterial Population |
https://ClinicalTrials.gov/show/NCT02417792 |
Completed |
Assuta Hospital Systems |
2019-01-06 |
| NCT02413801 |
Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients |
https://ClinicalTrials.gov/show/NCT02413801 |
Active, not recruiting |
University of Rochester |
2020-12-31 |
| NCT02376478 |
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection |
https://ClinicalTrials.gov/show/NCT02376478 |
Completed |
Medical University of Vienna |
2011-01-31 |
| NCT02330380 |
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation |
https://ClinicalTrials.gov/show/NCT02330380 |
Completed |
University Hospitals Cleveland Medical Center |
2016-12-31 |
| NCT02322580 |
An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients |
https://ClinicalTrials.gov/show/NCT02322580 |
Completed |
Universitaire Ziekenhuizen Leuven |
2016-09-30 |
| NCT02305953 |
Cytokines and Vascular Inflammation in Psoriasis |
https://ClinicalTrials.gov/show/NCT02305953 |
Completed |
Innovaderm Research Inc. |
2014-10-31 |
| NCT02274363 |
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis |
https://ClinicalTrials.gov/show/NCT02274363 |
Completed |
Janssen Pharmaceutica |
2013-05-31 |
| NCT02239666 |
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT02239666 |
Completed |
AstraZeneca |
2017-01-05 |
| NCT02192164 |
Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis |
https://ClinicalTrials.gov/show/NCT02192164 |
Completed |
Pfizer |
2016-05-31 |
| NCT02193919 |
A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy |
https://ClinicalTrials.gov/show/NCT02193919 |
Completed |
Bagel, Jerry, M.D. |
2008-05-31 |
| NCT02174367 |
An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis |
https://ClinicalTrials.gov/show/NCT02174367 |
Active, not recruiting |
King’s College London |
2017-07-31 |
| NCT02162472 |
Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis |
https://ClinicalTrials.gov/show/NCT02162472 |
Recruiting |
Northwestern University |
2020-12-31 |
| NCT02155192 |
An Exploratory Genetic Study in Participants With Psoriasis |
https://ClinicalTrials.gov/show/NCT02155192 |
Completed |
Janssen Research & Development, LLC |
2014-09-30 |
| NCT02078297 |
IL-17 Role in Variants of Psoriasis |
https://ClinicalTrials.gov/show/NCT02078297 |
Completed |
Innovaderm Research Inc. |
2015-02-28 |
| NCT01316224 |
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment |
https://ClinicalTrials.gov/show/NCT01316224 |
Completed |
AbbVie |
2014-04-30 |
| NCT03358693 |
Anti-cytokine Signatures in Inflammatory Skin Disease |
https://ClinicalTrials.gov/show/NCT03358693 |
Recruiting |
University of Schleswig-Holstein |
2024-12-31 |
| NCT03236870 |
A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China |
https://ClinicalTrials.gov/show/NCT03236870 |
Active, not recruiting |
AbbVie |
2020-09-30 |
| NCT01982552 |
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life |
https://ClinicalTrials.gov/show/NCT01982552 |
Completed |
LEO Pharma |
2014-01-31 |
| NCT01964443 |
Clinical Assessment and Psychosocial Impact of Psoriasis |
https://ClinicalTrials.gov/show/NCT01964443 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2015-11-30 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT01812954 |
Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis |
https://ClinicalTrials.gov/show/NCT01812954 |
Completed |
Technische Universität Dresden |
2014-06-30 |
| NCT01797224 |
OTIS Autoimmune Diseases in Pregnancy Project |
https://ClinicalTrials.gov/show/NCT01797224 |
Recruiting |
University of California, San Diego |
2020-01-31 |
| NCT01780857 |
Immune Signature of Palmoplantar Pustulosis |
https://ClinicalTrials.gov/show/NCT01780857 |
Completed |
Baylor Research Institute |
2014-07-31 |
| NCT01778569 |
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI) |
https://ClinicalTrials.gov/show/NCT01778569 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2030-06-30 |
| NCT01768858 |
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01768858 |
Completed |
AbbVie |
2017-08-13 |
| NCT01707368 |
Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation |
https://ClinicalTrials.gov/show/NCT01707368 |
Completed |
LEO Pharma |
2014-05-31 |
| NCT01706692 |
Swiss Dermatology Network of Targeted Therapies (SDNTT) |
https://ClinicalTrials.gov/show/NCT01706692 |
Recruiting |
Swiss Dermatology Network for Targeted Therapies |
2021-06-30 |
| NCT01677598 |
A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries |
https://ClinicalTrials.gov/show/NCT01677598 |
Completed |
Johnson & Johnson Pte Ltd |
2013-11-30 |
| NCT01623752 |
Prospective Evaluation of the Radiographic Efficacy of Enbrel |
https://ClinicalTrials.gov/show/NCT01623752 |
Completed |
Pfizer |
2018-03-31 |
| NCT01617018 |
Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis |
https://ClinicalTrials.gov/show/NCT01617018 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-07-31 |
| NCT01557283 |
An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria |
https://ClinicalTrials.gov/show/NCT01557283 |
Completed |
Pfizer |
2013-06-30 |
| NCT01555606 |
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT01555606 |
Completed |
Janssen Biotech, Inc. |
2012-07-31 |
| NCT01465061 |
A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT01465061 |
Completed |
University of the Philippines |
2011-06-30 |
| NCT01425138 |
Systematic Review And Meta-Analysis Of Psoriasis Treatments. |
https://ClinicalTrials.gov/show/NCT01425138 |
Completed |
Pfizer |
2011-06-30 |
| NCT01387815 |
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis |
https://ClinicalTrials.gov/show/NCT01387815 |
Completed |
AbbVie |
2018-06-29 |
| NCT01401452 |
Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities |
https://ClinicalTrials.gov/show/NCT01401452 |
Completed |
AbbVie |
2016-05-31 |
| NCT01356758 |
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents |
https://ClinicalTrials.gov/show/NCT01356758 |
Completed |
University of Aarhus |
2015-09-30 |
| NCT01328366 |
Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab |
https://ClinicalTrials.gov/show/NCT01328366 |
Completed |
AbbVie |
2014-05-31 |
| NCT01320774 |
Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris |
https://ClinicalTrials.gov/show/NCT01320774 |
Completed |
LEO Pharma |
2012-01-31 |
| NCT04380597 |
Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life |
https://ClinicalTrials.gov/show/NCT04380597 |
Active, not recruiting |
Complejo Hospitalario Universitario de Pontevedra |
2019-12-15 |
| NCT04277832 |
Evaluating of New Screening Tool for Arthritis* in Psoriasis |
https://ClinicalTrials.gov/show/NCT04277832 |
Recruiting |
Bezmialem Vakif University |
2020-08-31 |
| NCT04209894 |
A Clinical Study of Sub-clinical Enthesitis in Patients With Psoriasis and Healthy Controls |
https://ClinicalTrials.gov/show/NCT04209894 |
Active, not recruiting |
Fatih Sultan Mehmet Training and Research Hospital |
2020-11-15 |
| NCT04203693 |
Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT04203693 |
Recruiting |
Almirall, S.A. |
2023-07-31 |
| NCT04190758 |
GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden |
https://ClinicalTrials.gov/show/NCT04190758 |
Recruiting |
Vastra Gotaland Region |
2039-12-31 |
| NCT04168619 |
MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool |
https://ClinicalTrials.gov/show/NCT04168619 |
Recruiting |
The University of Hong Kong |
2020-12-31 |
| NCT04095130 |
Tissue Sodium in Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT04095130 |
Completed |
Charite University, Berlin, Germany |
2018-03-16 |
| NCT04099979 |
A Pilot Study to Explore the Role of Gut Flora in Psoriasis |
https://ClinicalTrials.gov/show/NCT04099979 |
Recruiting |
ProgenaBiome |
2023-03-31 |
| NCT04053881 |
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT04053881 |
Recruiting |
UCB Pharma |
2022-04-30 |
| NCT04031027 |
A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT04031027 |
Recruiting |
Amgen |
2020-07-30 |
| NCT04013867 |
Identification of the Best Self-questionnaire to Diagnose Depression in Patients With Psoriasis (DePsoVal) |
https://ClinicalTrials.gov/show/NCT04013867 |
Recruiting |
University Hospital, Clermont-Ferrand |
2019-11-16 |
| NCT03982394 |
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT03982394 |
Recruiting |
AbbVie |
2025-06-30 |
| NCT03964168 |
An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers |
https://ClinicalTrials.gov/show/NCT03964168 |
Completed |
Psoriasis Treatment Center of Central New Jersey |
2020-03-03 |
| NCT03955861 |
Ultrasound Enthesitis Response in Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT03955861 |
Recruiting |
Belfast Health and Social Care Trust |
2020-02-29 |
| NCT03925441 |
Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea |
https://ClinicalTrials.gov/show/NCT03925441 |
Completed |
AbbVie |
2019-08-06 |
| NCT03885089 |
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg “Pfizer” Drug Use Investigation (Psoriasis) |
https://ClinicalTrials.gov/show/NCT03885089 |
Recruiting |
Pfizer |
2023-03-13 |
| NCT03828643 |
Secukinumab Efficacy Without the Initial Loading Dose in Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT03828643 |
Completed |
Universita di Verona |
2019-04-12 |
| NCT03831646 |
Clinical, Psychological and Genetic Characteristics in Dermatological Patients |
https://ClinicalTrials.gov/show/NCT03831646 |
Completed |
Astana Medical University |
2019-07-10 |
| NCT03816917 |
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral |
https://ClinicalTrials.gov/show/NCT03816917 |
Enrolling by invitation |
Radboud University |
2021-12-01 |
| NCT03807453 |
Comparison of Scalp Microbiome of the Psoriasis and Seborrheic Dermatitis Patients |
https://ClinicalTrials.gov/show/NCT03807453 |
Completed |
Istanbul Medeniyet University |
2019-06-18 |
| NCT03791216 |
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment |
https://ClinicalTrials.gov/show/NCT03791216 |
Recruiting |
Northwestern University |
2020-12-31 |
| NCT03795402 |
Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling |
https://ClinicalTrials.gov/show/NCT03795402 |
Completed |
Janssen Research & Development, LLC |
2019-11-25 |
| NCT03768284 |
Genetic Analysis of Pediatric Psoriasis |
https://ClinicalTrials.gov/show/NCT03768284 |
Recruiting |
Northwestern University |
2020-10-31 |
| NCT03757364 |
Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Nail Psoriasis |
https://ClinicalTrials.gov/show/NCT03757364 |
Completed |
University of Warmia and Mazury |
2018-09-30 |
| NCT03757013 |
A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France |
https://ClinicalTrials.gov/show/NCT03757013 |
Recruiting |
Amgen |
2021-06-24 |
| NCT03616561 |
Quality of Life and Ultrasonographic Assessment of Nail Psoriasis After Treatment With Apremilast (JUST Study) |
https://ClinicalTrials.gov/show/NCT03616561 |
Active, not recruiting |
Hospital de Granollers |
2020-05-23 |
| NCT03539419 |
Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain |
https://ClinicalTrials.gov/show/NCT03539419 |
Recruiting |
Amgen |
2019-11-02 |
| NCT03492632 |
Ovarian Reserve in Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT03492632 |
Completed |
Kanuni Sultan Suleyman Training and Research Hospital |
2018-06-30 |
| NCT01262534 |
A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis. |
https://ClinicalTrials.gov/show/NCT01262534 |
Completed |
Janssen-Cilag, S.A. |
2011-06-30 |
| NCT01233583 |
Regulatory T-cells in Psoriasis Patients as Targets for Therapy |
https://ClinicalTrials.gov/show/NCT01233583 |
Completed |
University of Aberdeen |
2013-09-30 |
| NCT01202565 |
Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01202565 |
Completed |
AbbVie |
2013-07-31 |
| NCT01169987 |
Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life |
https://ClinicalTrials.gov/show/NCT01169987 |
Completed |
AbbVie |
2015-03-31 |
| NCT01155570 |
Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation) |
https://ClinicalTrials.gov/show/NCT01155570 |
Completed |
AbbVie |
2012-07-31 |
| NCT01139918 |
Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT01139918 |
Completed |
Innovaderm Research Inc. |
2014-07-31 |
| NCT01126619 |
A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis |
https://ClinicalTrials.gov/show/NCT01126619 |
Completed |
Abbott |
2011-09-30 |
| NCT01100034 |
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis |
https://ClinicalTrials.gov/show/NCT01100034 |
Completed |
Pfizer |
2018-09-24 |
| NCT01084668 |
Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs |
https://ClinicalTrials.gov/show/NCT01084668 |
Completed |
Abbott |
2011-04-30 |
| NCT01083121 |
Surveillance of Humira Injection in Korean Patients |
https://ClinicalTrials.gov/show/NCT01083121 |
Completed |
AbbVie |
2012-06-30 |
| NCT01081730 |
Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database |
https://ClinicalTrials.gov/show/NCT01081730 |
Completed |
Janssen Biotech, Inc. |
2017-09-29 |
| NCT01077232 |
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01077232 |
Completed |
AbbVie |
2019-06-30 |
| NCT01077128 |
Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab |
https://ClinicalTrials.gov/show/NCT01077128 |
Completed |
AbbVie |
2012-09-30 |
| NCT01076192 |
Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE) |
https://ClinicalTrials.gov/show/NCT01076192 |
Completed |
AbbVie |
2014-09-30 |
| NCT01052467 |
Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel) |
https://ClinicalTrials.gov/show/NCT01052467 |
Completed |
LEO Pharma |
2010-05-31 |
| NCT01019200 |
Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT01019200 |
Completed |
George Washington University |
2016-03-31 |
| NCT00998829 |
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT00998829 |
Completed |
Pfizer |
2012-05-31 |
| NCT00930592 |
Peds Metabolic Syndrome in Psoriasis |
https://ClinicalTrials.gov/show/NCT00930592 |
Completed |
Tufts Medical Center |
2012-07-31 |
| NCT00930384 |
A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT00930384 |
Completed |
George Washington University |
2016-04-30 |
| NCT00895375 |
Prevalence of Sleep Disturbances in Psoriasis |
https://ClinicalTrials.gov/show/NCT00895375 |
Completed |
Wake Forest University Health Sciences |
2011-02-28 |
| NCT00894777 |
Study Evaluating Management of Patients With Moderate and Severe Psoriasis |
https://ClinicalTrials.gov/show/NCT00894777 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2009-11-30 |
| NCT00893126 |
Premature Coronary Artery Disease (CAD) in Severe Psoriasis |
https://ClinicalTrials.gov/show/NCT00893126 |
Completed |
University of Michigan |
2016-03-31 |
| NCT00879944 |
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index |
https://ClinicalTrials.gov/show/NCT00879944 |
Completed |
Northwestern University |
2012-06-30 |
| NCT00830817 |
Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis |
https://ClinicalTrials.gov/show/NCT00830817 |
Completed |
Welichem Biotech Inc. |
2008-04-30 |
| NCT00823914 |
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life |
https://ClinicalTrials.gov/show/NCT00823914 |
Completed |
Massachusetts General Hospital |
2013-12-31 |
| NCT04149587 |
A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen |
https://ClinicalTrials.gov/show/NCT04149587 |
Recruiting |
Bausch Health Americas, Inc. |
2022-03-30 |
| NCT03149900 |
Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients |
https://ClinicalTrials.gov/show/NCT03149900 |
Completed |
University of Luebeck |
2019-07-25 |
| NCT03059953 |
A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The ‘APRAISAL’ Study) |
https://ClinicalTrials.gov/show/NCT03059953 |
Completed |
Genesis Pharma S.A. |
2018-04-06 |
| NCT03097003 |
A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium |
https://ClinicalTrials.gov/show/NCT03097003 |
Completed |
Amgen |
2018-12-20 |
| NCT02457000 |
Sleep, Circadian Rhythm & Skin Health |
https://ClinicalTrials.gov/show/NCT02457000 |
Active, not recruiting |
University Hospitals Cleveland Medical Center |
2020-12-31 |
| NCT03125655 |
Regulation of Inflammatory Genes in Psoriasis |
https://ClinicalTrials.gov/show/NCT03125655 |
Recruiting |
University of Alabama at Birmingham |
2021-04-10 |
| NCT00779675 |
Assessment of Long-Term Infliximab for Psoriasis (P05319) |
https://ClinicalTrials.gov/show/NCT00779675 |
Completed |
Merck Sharp & Dohme Corp. |
2011-10-31 |
| NCT00760669 |
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants |
https://ClinicalTrials.gov/show/NCT00760669 |
Completed |
Janssen Korea, Ltd., Korea |
2011-04-30 |
| NCT00749398 |
Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) |
https://ClinicalTrials.gov/show/NCT00749398 |
Completed |
Merck Sharp & Dohme Corp. |
2010-09-30 |
| NCT00727298 |
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) |
https://ClinicalTrials.gov/show/NCT00727298 |
Completed |
Merck Sharp & Dohme Corp. |
2011-08-31 |
| NCT00725452 |
Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900) |
https://ClinicalTrials.gov/show/NCT00725452 |
Completed |
Merck Sharp & Dohme Corp. |
2010-06-30 |
| NCT00708708 |
Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings |
https://ClinicalTrials.gov/show/NCT00708708 |
Completed |
Pfizer |
2013-12-31 |
| NCT00710489 |
Potential Research Study Participant Registry |
https://ClinicalTrials.gov/show/NCT00710489 |
Completed |
University of California, Davis |
2018-09-05 |
| NCT00658827 |
Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis |
https://ClinicalTrials.gov/show/NCT00658827 |
Completed |
Janssen Biotech, Inc. |
2016-09-30 |
| NCT00602823 |
Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva) |
https://ClinicalTrials.gov/show/NCT00602823 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00555178 |
Regulatory T Cells (Tregs) in Polymorphic Light Eruption |
https://ClinicalTrials.gov/show/NCT00555178 |
Completed |
Medical University of Graz |
2014-12-31 |
| NCT00799877 |
Chronic Plaque Psoriasis (Ps) Registry |
https://ClinicalTrials.gov/show/NCT00799877 |
Active, not recruiting |
AbbVie |
2022-09-15 |
| NCT00451243 |
Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment |
https://ClinicalTrials.gov/show/NCT00451243 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00437216 |
Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT00437216 |
Completed |
Galderma Laboratories, L.P. |
2006-07-31 |
| NCT00407979 |
Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis |
https://ClinicalTrials.gov/show/NCT00407979 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-02-28 |
| NCT00371163 |
Molecular and Cellular Characterization of Spongiotic Dermatitis |
https://ClinicalTrials.gov/show/NCT00371163 |
Completed |
University of California, Davis |
2012-12-31 |
| NCT00368784 |
T Cell Repertoire Analysis of Immune Mediated Skin Diseases |
https://ClinicalTrials.gov/show/NCT00368784 |
Recruiting |
University of California, Davis |
2021-10-31 |
| NCT00371774 |
Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.Eâ„¢) Program |
https://ClinicalTrials.gov/show/NCT00371774 |
Completed |
Astellas Pharma Inc |
2008-05-31 |
| NCT00341809 |
Genetic Analysis of Psoriasis and Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT00341809 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00293722 |
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists |
https://ClinicalTrials.gov/show/NCT00293722 |
Completed |
Pfizer |
2013-02-28 |
| NCT00293709 |
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists |
https://ClinicalTrials.gov/show/NCT00293709 |
Completed |
Pfizer |
2013-02-28 |
| NCT00261976 |
A Long-term Safety Study of Infliximab (Remicade) |
https://ClinicalTrials.gov/show/NCT00261976 |
Completed |
Centocor, Inc. |
2012-03-31 |
| NCT00227240 |
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis |
https://ClinicalTrials.gov/show/NCT00227240 |
Completed |
Pfizer |
2009-06-30 |
| NCT00167752 |
Psychiatric Problems in Chronic Skin Diseases |
https://ClinicalTrials.gov/show/NCT00167752 |
Completed |
University of Wisconsin, Madison |
2006-02-28 |
| NCT00162825 |
Role of CD7 in Skin Inflammation and Psoriasis |
https://ClinicalTrials.gov/show/NCT00162825 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00131066 |
Long-Term Follow-Up Study of Psoriasis Patients |
https://ClinicalTrials.gov/show/NCT00131066 |
Completed |
MedImmune LLC |
2003-10-31 |
| NCT00097240 |
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW) |
https://ClinicalTrials.gov/show/NCT00097240 |
Completed |
Genentech, Inc. |
NA |
| NCT00096928 |
A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) |
https://ClinicalTrials.gov/show/NCT00096928 |
Completed |
Genentech, Inc. |
NA |
| NCT00005781 |
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles |
https://ClinicalTrials.gov/show/NCT00005781 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001371 |
A Pilot Study of Topical Antiflammin-2 for Psoriasis |
https://ClinicalTrials.gov/show/NCT00001371 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00026741 |
Research in Skin Inflammation |
https://ClinicalTrials.gov/show/NCT00026741 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00303186 |
Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy |
https://ClinicalTrials.gov/show/NCT00303186 |
Completed |
Pfizer |
2011-06-30 |
| NCT00098189 |
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis |
https://ClinicalTrials.gov/show/NCT00098189 |
Completed |
Novartis |
NA |
| NCT00005660 |
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases |
https://ClinicalTrials.gov/show/NCT00005660 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001420 |
Study of Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT00001420 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |